These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20946551)

  • 1. Baseline heart rate variability predicts clinical events in heart failure patients implanted with cardiac resynchronization therapy: validation by means of related complexity index.
    Molon G; Solimene F; Melissano D; Curnis A; Belotti G; Marrazzo N; Marczyk J; Accardi F; Raciti G; Zecchi P
    Ann Noninvasive Electrocardiol; 2010 Oct; 15(4):301-7. PubMed ID: 20946551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure.
    Fantoni C; Raffa S; Regoli F; Giraldi F; La Rovere MT; Prentice J; Pastori F; Fratini S; Salerno-Uriarte JA; Klein HU; Auricchio A
    J Am Coll Cardiol; 2005 Nov; 46(10):1875-82. PubMed ID: 16286175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
    Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
    JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of serial heart rate variability measurement for prediction of appropriate ICD discharge in patients with heart failure.
    Ten Sande JN; Damman P; Tijssen JG; De Groot JR; Knops RE; Wilde AA; Van Dessel PF
    J Cardiovasc Electrophysiol; 2014 Jan; 25(1):60-5. PubMed ID: 24118293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma tissue inhibitor of matrix metalloproteinase-1 a predictor of long-term mortality in patients treated with cardiac resynchronization therapy.
    Trucco E; Tolosana JM; Castel MÁ; Batlle M; Borràs R; Sitges M; Guash E; Matas M; Arbelo E; Berruezo A; Brugada J; Mont L
    Europace; 2016 Feb; 18(2):232-7. PubMed ID: 25883077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cardiac resynchronization treatment on autonomic functions aside from functional status in heart failure.
    Arslan U; Balcı MM; Kocaoğlu İ; Çimen T; Kalaycı S; Temizhan A
    Anadolu Kardiyol Derg; 2013 Aug; 13(5):439-45. PubMed ID: 23665985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
    Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
    Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of Heart Rate Variability Among Patients Treated With Cardiac Resynchronization Therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy).
    Sherazi S; Kutyifa V; McNitt S; Aktas MK; Couderc JP; Peterson B; Bloch Thomsen PE; Kautzner J; Moss AJ; Zareba W
    JACC Clin Electrophysiol; 2015; 1(1-2):74-80. PubMed ID: 29759342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in heart rate variability, quality of life, and activity in cardiac resynchronization therapy patients: results of the HF-HRV registry.
    Gilliam FR; Kaplan AJ; Black J; Chase KJ; Mullin CM
    Pacing Clin Electrophysiol; 2007 Jan; 30(1):56-64. PubMed ID: 17241316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implication of baseline PR interval in cardiac resynchronization therapy recipients.
    Januszkiewicz Ł; Vegh E; Borgquist R; Bose A; Sharma A; Orencole M; Mela T; Singh JP; Parks KA
    Heart Rhythm; 2015 Nov; 12(11):2256-62. PubMed ID: 26066291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of cardiac resynchronization therapy device implantation in heart failure patients and its association with outcomes.
    Goldstein SA; Mentz RJ; Hellkamp AS; Randolph TC; Fonarow GC; Hernandez A; Yancy CW; Al-Khatib SM
    Clin Cardiol; 2019 Feb; 42(2):256-263. PubMed ID: 30548280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
    Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
    Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning-based phenogrouping in heart failure to identify responders to cardiac resynchronization therapy.
    Cikes M; Sanchez-Martinez S; Claggett B; Duchateau N; Piella G; Butakoff C; Pouleur AC; Knappe D; Biering-Sørensen T; Kutyifa V; Moss A; Stein K; Solomon SD; Bijnens B
    Eur J Heart Fail; 2019 Jan; 21(1):74-85. PubMed ID: 30328654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of hyponatremia as a predictor for adverse events in patients with heart failure receiving cardiac resynchronization therapy.
    Sharma AK; Vegh EM; Kandala J; Orencole M; Januszkiewicz L; Bose A; Miller A; Parks KA; Heist EK; Singh JP
    Am J Cardiol; 2014 Jul; 114(1):83-7. PubMed ID: 24852916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy.
    Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C
    Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The VALID-CRT risk score reliably predicts response and outcome of cardiac resynchronization therapy in a real-world population.
    Bertaglia E; Arena G; Pecora D; Reggiani A; D'Onofrio A; Palmisano P; De Simone A; Caico SI; Marini M; Maglia G; Ferraro A; Solimene F; Cecchetto A; Malacrida M; Botto GL; Lunati M; Stabile G
    Clin Cardiol; 2019 Oct; 42(10):919-924. PubMed ID: 31301152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of Electrocardiographic Left Atrial Abnormality to Predict Response to Cardiac Resynchronization Therapy in Patients With Mild Heart Failure and Left Bundle Branch Block (a Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy).
    Baturova MA; Kutyifa V; McNitt S; Polonsky B; Solomon S; Carlson J; Zareba W; Platonov PG
    Am J Cardiol; 2018 Jul; 122(2):268-274. PubMed ID: 29861050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients.
    Nagy KV; Széplaki G; Perge P; Boros AM; Kosztin A; Apor A; Molnár L; Szilágyi S; Tahin T; Zima E; Kutyifa V; Gellér L; Merkely B
    Europace; 2018 Sep; 20(9):1506-1512. PubMed ID: 29182734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.